Condition Overview

Rheumatoid Arthritis

For people under rheumatology care who ask about supportive options alongside it.

Book a Consultation Am I a Candidate?

or call (818) 938-9023

Cellular artwork for Rheumatoid Arthritis Personalized review, grounded in your health history.
Overview

Understanding rheumatoid arthritis

Rheumatoid arthritis is a chronic autoimmune disease that most often affects joints, causing pain, swelling, stiffness, and loss of function. It can also affect the lungs, heart, blood, nerves, eyes, and skin. Early and ongoing treatment matters because uncontrolled inflammation can lead to lasting joint damage and other complications.

Established care is led by a rheumatologist and may include disease-modifying medication, monitoring, rehabilitation, activity planning, and management of related health risks. Cellular and regenerative approaches are being studied, but they are not a replacement for disease-modifying treatment or monitoring. Much of the regenerative research people have read about concerns osteoarthritis, which is a different disease, and findings there do not transfer to rheumatoid arthritis. Rheumatoid arthritis is driven by systemic immune activity, which is why disease-modifying medication remains the foundation of care.

Our consultation reviews your diagnosis, disease activity, current medication, recent stability, and goals. A licensed provider explains the limits of the research and decides whether any supportive assessment is appropriate. Medication changes remain the responsibility of your rheumatologist.

Some situations need urgent attention rather than a consultation. If you take immune-modifying medication and develop a fever, chills, or a suspected infection, contact your rheumatologist the same day. Chest pain, sudden shortness of breath, or a single hot, severely swollen and painful joint need emergency care now: call 911 or go to an emergency department.

Possibilities

Potential Benefits

A rheumatoid arthritis consultation may help you:

  • A review of your diagnosis, your current disease activity, and your recent stability
  • A clear account of what cell-based research has and has not established in inflammatory arthritis
  • Screening against the factors that make supportive care inappropriate
  • Questions to discuss with your rheumatologist
  • A direct answer, including when that answer is no
Considerations

Who May Benefit

A rheumatoid arthritis assessment may make sense for people including:

  • Adults with confirmed rheumatoid arthritis under rheumatology care
  • People whose disease and medication plan are clinically stable
  • Individuals seeking a clear explanation of emerging research
  • People willing to share current medication and laboratory information
  • Adults who understand that disease-modifying care must continue
Related Care

Therapies a Provider May Consider

Every option is reviewed individually after your history, current care, and goals are understood.

  • Physician Guided

Exosome Therapy

Exosome therapy works with the signaling vesicles your cells already use to communicate. Studied for recovery, skin quality and healthy aging, and always planned by a licensed provider.

Learn More about Exosome Therapy
  • Physician Guided

NAD+ Therapy

NAD+ is the coenzyme your cells use to turn food into energy, and levels fall with age. A leading choice for support with energy, mental clarity and recovery.

Learn More about NAD+ Therapy
  • Physician Guided

MUSE Cell Therapy

A stress enduring cell type able to develop into many tissue types. Explored for healthy aging, recovery and whole body cellular wellness, always guided by clinical review.

Learn More about MUSE Cell Therapy
  • Physician Guided

Stem Cell Therapy

The body's own building and repair cells, and the foundation of regenerative medicine. Explored for recovery, mobility and healthy aging through physician guided planning.

Learn More about Stem Cell Therapy
Evidence

What the Research Looks At

Rheumatoid arthritis has established disease-modifying treatment pathways. Cellular research remains experimental and does not support replacing rheumatology care. These references provide condition guidance, regulatory context, and registered-study information.

  1. Rheumatoid Arthritis National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
  2. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes U.S. Food and Drug Administration
  3. Registered clinical trials related to Rheumatoid Arthritis ClinicalTrials.gov, U.S. National Library of Medicine
Your Next Step

Start With an Assessment

Every visit begins with a consultation and a medical screening. A licensed provider decides what, if anything, is appropriate for you.

Book a Consultation

or call (818) 938-9023

Terms you may hear when discussing rheumatoid arthritis

Rheumatology has precise vocabulary for medication and disease control, and it appears in every clinic letter. These are the terms a provider here will ask about.

  • DMARD. Disease-modifying antirheumatic drug, the category of medication that slows the underlying disease rather than only easing symptoms. Methotrexate is the most common conventional DMARD. They are prescribed and monitored by your rheumatologist.
  • Biologic. A targeted DMARD, usually given by injection or infusion, that blocks a specific part of the immune response. Biologics suppress immunity, which is one of the things weighed in any screening.
  • Disease activity. How active the inflammation is right now, judged from tender and swollen joint counts, blood markers such as CRP and ESR, and how you feel. Low disease activity or remission is the goal of treatment.
  • Seropositive. Having rheumatoid factor or anti-CCP antibodies in the blood. It is one of the details in your diagnosis and can influence how the disease is expected to behave.

A licensed provider reviews your diagnosis, disease activity, current medication, recent stability and goals before deciding whether anything here is appropriate to consider alongside your rheumatologist’s plan. Nothing offered is a treatment for rheumatoid arthritis, and disease-modifying medication remains the foundation of care.

Related conditions in this care area: Lupus, SLE, Sarcopenia and Age-Related Muscle Loss and Healthy Aging and General Wellness. Back to Longevity and Vitality.

Rheumatoid Arthritis

Frequently Asked Questions

No. Nothing offered here is a cure or an approved treatment for rheumatoid arthritis. The purpose of the consultation is to review your history, explain the limits of current research, and decide whether any supportive assessment is appropriate.
No. Disease-modifying medication, laboratory monitoring, and any change to your treatment stay with your rheumatologist. Reducing or stopping disease-modifying medication can cause lasting joint damage, and it is not a conversation to have here.
You share intake information, your current medication, and recent laboratory results, then complete a medical screening. A licensed provider reviews your disease activity, your current care, and your goals, and will ask what you are hoping to change that your current treatment is not already doing. Only after that review can the provider decide whether any next step is appropriate.
A licensed provider makes that decision after reviewing your history and screening information. Not everyone is eligible, and being told that no further step is appropriate is a normal outcome of an honest assessment.
Hitech Regen serves Southern California. Availability and suitability are discussed during the consultation before any visit is scheduled.
Cost is discussed after a licensed provider determines whether anything is appropriate to consider. We do not quote a condition-specific plan before the assessment.
No, and please do not. Disease-modifying drugs and biologics in rheumatoid arthritis are prescribed, monitored and adjusted by a rheumatologist. We do not manage rheumatoid arthritis and we do not change prescribed medication. Any change to a DMARD or biologic is a conversation with your rheumatologist, not with us.
Yes, and you should say so at intake. Being immunosuppressed changes what is safe to consider, and it is one of the things a licensed provider weighs during the medical screening before deciding whether anything is appropriate.
We make no claim of that kind. Nothing offered here is a cure and no product we work with is FDA approved for rheumatoid arthritis. Existing structural joint damage and how it is monitored belong to your rheumatologist.
Book the consultation if you want the conversation, but tell us you are flaring. An active flare is managed by your rheumatologist, and it is relevant to whether the provider considers anything here appropriate at that moment.
Book a Consultation